Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, L. A., Peterson, B. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
-
Predictors of Myelodysplastic Syndrome in Minnesota
Poynter, J., Cioc, A. M., Hirsch, B. A. & Warlick, E. D.
NIH NATIONAL CANCER INSTITUTE (NCI)
3/5/18 → 2/28/23
Project: Research project
-
Cancer Center Support Grant
Yee, D., Bagchi, A., Bielinsky, A. K., Bitterman, P. B., Cooley, S. A., Gupta, K., Hatsukami, D. K., Hecht, S. S., Hirsch, B. A., Jacobson, P. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Kratzke, R. A., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Lazovich, D., Le, C. T., Mc Carthy, J. B., Miller, J. S., O'Sullivan, G., Okuyemi, K., Pennell, C. A., Shimizu, Y., Sumpmann, M., Verneris, M. R., Vickers, S., Wagner, J. E., Weigel, B. J. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
3/5/14 → 1/31/19
Project: Research project
-
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report from the Children's Oncology Group AAML1331 Trial
Kutny, M. A., Alonzo, T. A., Abla, O., Rajpurkar, M., Gerbing, R. B., Wang, Y. C., Hirsch, B. A., Raimondi, S., Kahwash, S., Hardy, K. K., Hardy, S., Meshinchi, S., Gamis, A. S., Kolb, E. A., Feusner, J. H. & Gregory, J., Jan 2022, In: JAMA Oncology. 8, 1, p. 79-87 9 p.Research output: Contribution to journal › Article › peer-review
-
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group
Getz, K. D., Alonzo, T. A., Sung, L., Meshinchi, S., Gerbing, R. B., Raimondi, S., Hirsch, B., Loken, M., Brodersen, L. E., Kahwash, S., Choi, J., Kolb, E. A., Gamis, A. & Aplenc, R., Sep 2 2021, In: Pediatric Blood and Cancer. 69, 1, e29313.Research output: Contribution to journal › Article › peer-review
-
Deletion at an 1q24 locus reveals a critical role of long noncoding RNA DNM3OS in skeletal development
Yu, T. T., Xu, Q. F., Li, S. Y., Huang, H. J., Dugan, S., Shao, L., Roggenbuck, J. A., Liu, X. T., Liu, H. Z., Hirsch, B. A., Yue, S., Liu, C. & Cheng, S. Y., Mar 2 2021, In: Cell and Bioscience. 11, 1, 47.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children’s Oncology Group Trial AAML0531
Pollard, J. A., Guest, E., Alonzo, T. A., Gerbing, R. B., Loken, M. R., Brodersen, L. E., Anders Kolb, E., Aplenc, R., Meshinchi, S., Raimondi, S. C., Hirsch, B. & Gamis, A. S., Oct 1 2021, In: Journal of Clinical Oncology. 39, 28, p. 3149-3160 12 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial
Hitzler, J., Alonzo, T., Gerbing, R., Beckman, A., Hirsch, B., Raimondi, S., Chisholm, K., Viola, S., Brodersen, L., Loken, M., Tong, S., Druley, T., O'Brien, M., Hijiya, N., Heerema-McKenney, A., Wang, Y. C., Shore, R., Taub, J., Gamis, A., Kolb, E. A. & 1 others, , Dec 9 2021, In: Blood. 138, 23, p. 2337-2346 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations